Literature DB >> 8639093

Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation.

S E Coupland1, S Sidiki, B J Clark, K McClaren, P Kyle, W R Lee.   

Abstract

Metastatic uveal melanoma to the contralateral orbit is extremely rare, with only eight cases in the literature having been reported. We reviewed the clinical presentation, the histologic findings of the primary and secondary tumors, and the clinical outcome of these cases and studied an additional case of metastatic choroidal melanoma to the contralateral orbit that occurred 40 years after enucleation for the primary tumor. The long interval between recognition of the primary tumor and the appearance of clinically manifest metastatic disease in the contralateral orbit is the longest reported in the literature to date. The histologic features of the tumor cells of the enucleation specimen and those of the orbital metastasis were similar, consisting of spindle-cell type with minimal atypia. Combined use of immuno-phenotyping and electron microscopy substantiated the diagnosis of melanoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639093     DOI: 10.1001/archopht.1996.01100130743022

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.

Authors:  Kyra N Smit; Natasha M van Poppelen; Jolanda Vaarwater; Robert Verdijk; Ronald van Marion; Helen Kalirai; Sarah E Coupland; Sophie Thornton; Neil Farquhar; Hendrikus-Jan Dubbink; Dion Paridaens; Annelies de Klein; Emine Kiliç
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

2.  Treated choroidal melanoma with late metastases to the contralateral orbit.

Authors:  Sonia George; Carole A Cooke; Gerald F Mc Ginnity; Steve White; Laksmi Venkatraman
Journal:  Clin Med Pathol       Date:  2009-04-03

3.  Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.

Authors:  James J Augsburger; Zélia M Corrêa; Adeel H Shaikh
Journal:  Trans Am Ophthalmol Soc       Date:  2008

4.  Chemoreduction of Orbital Recurrence of Uveal Melanoma by Intra-Arterial Melphalan.

Authors:  Jasmine H Francis; Christopher A Barker; Vivian T Yin; Richard D Carvajal; Paul Chapman; David H Abramson; Y Pierre Gobin
Journal:  Ocul Oncol Pathol       Date:  2018-10-09

5.  Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time.

Authors:  Christine D M Roelofsen; Annemijn P A Wierenga; Sjoerd van Duinen; Robert M Verdijk; Jaco Bleeker; Marina Marinkovic; Gregorius P M Luyten; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2020-12-15

6.  Presentation, Treatment, and Prognosis of Secondary Melanoma within the Orbit.

Authors:  Anna M Rose; Sophie Cowen; Channa N Jayasena; David H Verity; Geoffrey E Rose
Journal:  Front Oncol       Date:  2017-06-23       Impact factor: 6.244

7.  Bone Marrow Involvement in Melanoma. Potentials for Detection of Disseminated Tumor Cells and Characterization of Their Subsets by Flow Cytometry.

Authors:  Olga Chernysheva; Irina Markina; Lev Demidov; Natalia Kupryshina; Svetlana Chulkova; Alexandra Palladina; Alina Antipova; Nikolai Tupitsyn
Journal:  Cells       Date:  2019-06-21       Impact factor: 6.600

Review 8.  Hypoxia-dependent drivers of melanoma progression.

Authors:  Simona D'Aguanno; Fabiana Mallone; Donatella Del Bufalo; Antonietta Moramarco; Marco Marenco
Journal:  J Exp Clin Cancer Res       Date:  2021-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.